Probiotics for the Treatment of Atopic Dermatitis in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Objective: Atopic dermatitis (AD) is a prevalent, burdensome, and psychologically important pediatric concern. It has been reported that the intervention of interest is the use of probiotics for treatment of AD in children. Some reports have assessed the efficacy of probiotics in AD in children; however, evidence for their use has yet to be firmly established. Methods: To assess the effects of probiotics on AD in children, the PubMed/Medline, Cochrane Library Scopus, and OVID databases were searched for reports published in the English language. Results: Thirteen studies were identified. Significantly higher SCORAD values favoring probiotics over controls were observed (mean difference [MD], –3.07; 95% confidence interval [CI], –6.12 to –0.03; P < 0.001). The reported efficacy of probiotics in children < 1 year old was –1.03 (95%CI, –7.05 to 4.99) and that in children 1–18 years old was –4.50 (95%CI, –7.45 to –1.54; P < 0.001). Subgroup assessment showed in Europe, no effect of probiotics on SCORAD, whereas significantly lower SCORAD values were reported for Asia (MD, –5.39; 95%CI, –8.91 to –1.87). Lactobacillus rhamnosus GG (MD, 3.29; 95%CI, –0.30 to 6.88; P = 0.07) and Lactobacillus plantarum (MD, –0.70; 95%CI, –2.30 to 0.90; P = 0.39) showed no significant effect on SCORAD values in children with AD. However, Lactobacillus fermentum (MD, –11.42; 95%CI, –13.81 to –9.04), Lactobacillus salivarius (MD, –7.21; 95%CI, –9.63 to –4.78), and a mixture of different strains (MD, –3.52; 95%CI, –5.61 to –1.44) showed significant effects on SCORAD values in children with AD. Conclusions: Finding from this meta-analysis might not draw a robust conclusion that probiotics have beneficial effects on treating children with AD. Moreover, caution is needed when generalizing our results due to heterogeneity in the populations studied. More adequately powered randomized controlled trials involving larger samples are necessary to determine which species of probiotics and dosages and what periods of treatment are most efficacious against AD in children.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weidinger, S., & Novak, N. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00149-x · Cited by 1,908
Huang, R., Wang, K., & Hu, J. (2016) · Nutrients · doi:10.3390/nu8080483 · Cited by 505
Self-citationMeta-analysis, funnel plots and sensitivity analysis
Copas, J. (2000) · Biostatistics · doi:10.1093/biostatistics/1.3.247 · Cited by 503 · cited 2×
“…3 months LP,LF(2 × 1010 CFU,qd); Mixture(4 × 1010 CFU,qd) SCORAD decrease significantly in probiotic group compared to placebo In meta-analyses, sensitivity analyses are conducted by excluding studies one-by-one to identify those studies that materially affect the results (Copas and Shi, 2000).”
MethodA randomized trial of Lactobacillus plantarum CJLP 133 for the treatment of atopic dermatitis
Han, Y., Kim, B., Ban, J., Lee, J., Kim, B. J., Choi, B. S., Hwang, S., Ahn, K., & Kim, J. (2012) · Pediatric Allergy and Immunology · doi:10.1111/pai.12010 · Cited by 127
Cited by
Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview
Piqué, N., Berlanga, M., & Miñana-Galbis, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102534 · Cited by 642
Lactobacillus spp. for Gastrointestinal Health: Current and Future Perspectives
Dempsey, E., & Corr, S. C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.840245 · Cited by 579
Wollenberg, A., Christen‐Zäch, S., Taieb, A., Paul, C., Thyssen, J. P., de Bruin‐Weller, M., Vestergaard, C., Seneschal, J., Werfel, T., Cork, M. J., et al. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16892 · Cited by 493
The Lactobacillus casei group: history and health related applications
Hill, D., Sugrue, I., Tobin, C., Hill, C., Stanton, C., & Ross, R. P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02107 · Cited by 318
“Using species-specific PCR and high-resolution melting (HRM) analysis on 201 strains from international culture collections belonging to the L. casei group, it was determined that 46 strains were different from their previous classification (Iacumin et al., 2015).”
MethodSkin Barrier Function and the Microbiome
Lee, H.-J., & Kim, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113071 · Cited by 317
Probiotics as an alternative antimicrobial therapy: Current reality and future directions
Silva, D. R., Sardi, J. D. C. O., Pitangui, N. D. S., Roque, S. M., Silva, A. C. B. D., & Rosalen, P. L. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104080 · Cited by 311
Jiang, W., Ni, B., Liu, Z., Liu, X., Xie, W., Wu, I. X. Y., & Li, X. (2020) · Pediatric Drugs · doi:10.1007/s40272-020-00410-6 · Cited by 91
Wei, X., Jiang, P., Liu, J., Sun, R., & Zhu, L. (2020) · Journal of Asthma · doi:10.1080/02770903.2018.1561893 · Cited by 91
“For example, Lactobacillus salivarius and Lactobacillus fermentum were effective, while Lactobacillus plantarum had no effect against allergy [49].”
BackgroundProbiotics: Origin, Products, and Regulations in India
Narula, A. (2021) · Microorganisms for Sustainability · doi:10.1007/978-981-16-1947-2_4 · Cited by 6
Metadata
- Authors
- Huang, R., Ning, H., Shen, M., Li, J., Zhang, J., & Chen, X.
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2017-09-06
- Volume
- 7
- Pages
- 392-392
- ISSN
- 2235-2988 (ISSN-L)
- OpenAlex
- W2753804395
- Cited by
- 154
- References
- 4
- FWCI
- 2.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.